The S&P500 ended in the green (+0.32%) for the 5th time in 6 sessions, the same for the Nasdaq with +0.35%, with the Dow Jones coming out on top with +0.38%.
Tesla +15.3% (agreement in China to launch 'automatic driving' technology), Boeing (+3.4%) and Apple (+2.5%) supported the 3 main US indices.
Alphabet, which had soared +12% last week, lost -3.4%, Meta -2.4% (investments in AI continue to cause concern), Intel -1.6% and Microsoft -1%.
Biotechs and labs performed well, with Moderna +3.4%, Biogen +3.2% and Amgen +2.4%.

After a week of rebounding - which turned out to be the most bullish of the year - investors were keen to extend the movement that began last Monday, and to start the week with an assumed capital of confidence, despite uncertainties over the tone of the FED's statement on Wednesday evening (following its FOMC meeting) and the "elements of language" that will be distilled at Jerome Powell's press conference.

The bond sector played in favor of equities, with yields easing from -2.5Pts (on the 2-year) to -5.5Pts on the 10-year (towards 6.615%).
No rate changes are expected on Wednesday evening, but investors will once again be looking to Jerome Powell, who may be hardening his stance on inflation.
The latest price indices - including the famous PCE - in the USA have rekindled fears of a later-than-expected monetary easing by the Federal Reserve, which may not materialize until November.
The big news of the first 4 months of the year is the week-by-week evaporation of expectations of rate cuts (from 7 to... potentially zero) over the course of 2024, with a rate hike even garnering 33% of votes for January 2025.

Employment figures, due out on Friday, could also testify to the strength of the US economy, with 250,000 jobs expected to be created in April.000 jobs are expected to be created in April, compared with 303,000 in March.
Wednesday evening was punctuated by NXP Semiconductor's results: EPS earnings came in slightly ahead of expectations at $3.24/share, compared with $3.16/share, but sales were perfectly in line with consensus at $3.13 billion (the stock gained +3% in the after-hours).

Copyright (c) 2024 CercleFinance.com. All rights reserved.